Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Formation of the Platelet Plug01:22

Formation of the Platelet Plug

6.2K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.2K
Structure and Function of Platelets01:18

Structure and Function of Platelets

6.9K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
6.9K
Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors01:20

Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors

1.6K
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
1.6K
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

5.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
5.9K
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

342
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
342
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

1.1K
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
1.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hypoattenuated Leaflet Thickening After TAVR: Incidence, Predictors, and the Role of Platelet Reactivity: A Prospective Multicenter Observational Study.

Journal of clinical medicine·2026
Same author

Telomere length dynamics do not predict subclinical atherosclerosis progression over a six-year period.

GeroScience·2026
Same author

Impact of Supranormal LVEF After TAVI: Behavior, Mortality, and Cardiac Structure.

Journal of clinical medicine·2026
Same author

The Long-Term Outcomes of Corticosteroid Use in COVID-19 Patients with Cardiovascular Disease: A Propensity-Matched Analysis from the Multi-Center International Prospective Registry (HOPE-2).

Biomedicines·2025
Same author

Temporal trends and outcomes of left atrial appendage closure. A national population-based study.

Revista espanola de cardiologia (English ed.)·2025
Same author

Beta-Blockers after Myocardial Infarction without Reduced Ejection Fraction.

The New England journal of medicine·2025

Related Experiment Video

Updated: Apr 26, 2026

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.7K

Platelet function in Takotsubo cardiomyopathy.

Iván J Núñez-Gil1, Esther Bernardo, Gisela Feltes

  • 1Cardiovascular Institute, Hospital Clínico San Carlos, Madrid, Spain, ibnsky@yahoo.es.

Journal of Thrombosis and Thrombolysis
|July 24, 2014
PubMed
Summary
This summary is machine-generated.

Takotsubo cardiomyopathy (TK) involves stress-induced heart dysfunction. Elevated epinephrine in TK patients correlates with increased platelet activation, suggesting a role for platelets in the condition’s progression.

More Related Videos

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

1.2K
Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
06:32

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Published on: May 2, 2025

922

Related Experiment Videos

Last Updated: Apr 26, 2026

Microfluidics in Assessing Platelet Function
06:47

Microfluidics in Assessing Platelet Function

Published on: November 8, 2024

1.7K
Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation
04:37

Comprehensive Analysis of Procoagulant Platelets Exhibiting Features of Necrosis, Apoptosis and Platelet Activation

Published on: May 23, 2025

1.2K
Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor
06:32

Dynamic Multiparameter Platelet Function Assessment Using a Capacitive Biosensor

Published on: May 2, 2025

922

Area of Science:

  • Cardiology
  • Hematology
  • Pathophysiology

Background:

  • Takotsubo cardiomyopathy (TK) is characterized by transient left ventricular dysfunction without obstructive coronary artery disease, often triggered by stressful events.
  • Catecholamines, released during stress, are known to activate platelets.
  • The role of platelet activation in the pathophysiology of TK remains incompletely understood.

Purpose of the Study:

  • To investigate the influence of platelet activation in patients diagnosed with Takotsubo cardiomyopathy (TK).
  • To compare platelet reactivity in TK patients with those experiencing acute coronary syndrome (ACS) and healthy volunteers.
  • To explore the relationship between circulating catecholamine levels and platelet activation in TK.

Main Methods:

  • A cohort study including 32 TK patients, 13 ACS patients, and 18 healthy volunteers.
  • Blood samples were collected at admission and 3-month follow-up for platelet reactivity assessment.
  • Clinical, ECG, echocardiographic, and angiographic data were recorded. Circulating epinephrine levels were measured during the acute phase.

Main Results:

  • No significant differences in acute platelet reactivity were observed between TK and ACS patients.
  • Circulating epinephrine levels were significantly higher in TK patients during the acute phase.
  • At 3-month follow-up, TK patients showed elevated platelet activation and aggregation compared to ACS patients, linked to differences in antithrombotic therapy.
  • Higher acute epinephrine levels in TK patients were associated with increased platelet reactivity at follow-up.

Conclusions:

  • Platelet activation is elevated in Takotsubo cardiomyopathy (TK) patients, particularly those with higher acute epinephrine levels.
  • While acute platelet aggregation is similar between TK and ACS, long-term reactivity differs, influenced by medication.
  • These findings highlight the potential role of catecholamine-driven platelet activation in TK pathophysiology and long-term outcomes.